CJC1295 with DAC
Research Compound · 1 vial x 5mg
$45
| Pack size | 1 vial x 5mg |
| Also known as | DAC-GRF |
| Compound type | Synthetic GHRH analog with drug affinity complex |
| Sequence | YaDAIFTQSYRKVLAQLSARKLLQDILSR-K(MPA)-NH2 (a = D-Ala; MPA = maleimidopropionyl) |
| Molecular formula | C165H269N47O46 |
| Molecular weight | 3647.3 g/mol |
| Form | Lyophilized powder |
| Purity | 99% Pure |
| Storage | Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol. |
| Intended use | Laboratory research only |
This product is sold exclusively for laboratory research use by qualified professionals and institutions. It is not a drug, food, cosmetic, or dietary supplement, and is not approved for use in humans or animals. Handling must be performed only by trained personnel in a controlled research setting.
Research overview
CJC-1295 with DAC is a growth hormone-releasing hormone (GHRH) analog with an added lysine bearing a maleimidopropionic acid group, its "drug affinity complex" (DAC). The DAC binds serum albumin, which increases the peptide’s stability in plasma and extends its activity well beyond that of the non-DAC version.
Research areas
- GHRH receptor signaling
- Albumin-binding half-life extension
- Growth hormone release
Sources
Handling and storage
Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol.